5/29
10:50 am
eypt
Investing in EyePoint Pharmaceuticals (NASDAQ:EYPT) a year ago would have delivered you a 91% gain [Yahoo! Finance]
Low
Report
Investing in EyePoint Pharmaceuticals (NASDAQ:EYPT) a year ago would have delivered you a 91% gain [Yahoo! Finance]
5/16
07:00 am
eypt
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Medium
Report
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
5/13
08:09 am
eypt
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its price target lowered by analysts at HC Wainwright from $33.00 to $30.00. They now have a "buy" rating on the stock.
Medium
Report
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its price target lowered by analysts at HC Wainwright from $33.00 to $30.00. They now have a "buy" rating on the stock.
5/10
12:31 am
eypt
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
5/8
08:07 am
eypt
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its price target lowered by analysts at Robert W. Baird from $46.00 to $38.00. They now have an "outperform" rating on the stock.
Low
Report
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its price target lowered by analysts at Robert W. Baird from $46.00 to $38.00. They now have an "outperform" rating on the stock.
5/8
07:08 am
eypt
EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Developments [Yahoo! Finance]
Low
Report
EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Developments [Yahoo! Finance]
5/8
07:00 am
eypt
EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Developments
Low
Report
EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Developments
5/7
09:05 am
eypt
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its price target lowered by analysts at Chardan Capital from $39.00 to $28.00. They now have a "buy" rating on the stock.
Medium
Report
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its price target lowered by analysts at Chardan Capital from $39.00 to $28.00. They now have a "buy" rating on the stock.
5/7
08:01 am
eypt
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its price target lowered by analysts at Mizuho from $39.00 to $30.00. They now have a "buy" rating on the stock.
Medium
Report
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its price target lowered by analysts at Mizuho from $39.00 to $30.00. They now have a "buy" rating on the stock.
5/6
07:26 am
eypt
EyePoint Pharmaceuticals Announces Topline Data from the Phase 2 PAVIA Trial of DURAVYU™ in Non-Proliferative Diabetic Retinopathy [Yahoo! Finance]
High
Report
EyePoint Pharmaceuticals Announces Topline Data from the Phase 2 PAVIA Trial of DURAVYU™ in Non-Proliferative Diabetic Retinopathy [Yahoo! Finance]
5/6
07:00 am
eypt
EyePoint Pharmaceuticals Announces Topline Data from the Phase 2 PAVIA Trial of DURAVYU™ in Non-Proliferative Diabetic Retinopathy
High
Report
EyePoint Pharmaceuticals Announces Topline Data from the Phase 2 PAVIA Trial of DURAVYU™ in Non-Proliferative Diabetic Retinopathy
4/16
07:00 am
eypt
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Low
Report
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
4/2
07:05 am
eypt
EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists [Yahoo! Finance]
Low
Report
EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists [Yahoo! Finance]
4/2
07:00 am
eypt
EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists
Low
Report
EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists
3/18
07:00 am
eypt
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Low
Report
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
3/9
08:48 am
eypt
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Analysts Just Slashed This Year's Revenue Estimates By 22% [Yahoo! Finance]
Medium
Report
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Analysts Just Slashed This Year's Revenue Estimates By 22% [Yahoo! Finance]
3/8
09:47 am
eypt
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/8
05:52 am
eypt
EyePoint Pharmaceuticals Full Year 2023 Earnings: Beats Expectations [Yahoo! Finance]
Medium
Report
EyePoint Pharmaceuticals Full Year 2023 Earnings: Beats Expectations [Yahoo! Finance]
3/7
01:39 pm
eypt
EyePoint Pharmaceuticals Inc (EYPT) Reports Growth Amidst Strategic Shifts in Q4 and Full-Year 2023 [Yahoo! Finance]
Low
Report
EyePoint Pharmaceuticals Inc (EYPT) Reports Growth Amidst Strategic Shifts in Q4 and Full-Year 2023 [Yahoo! Finance]
3/7
10:50 am
eypt
Compared to Estimates, EyePoint Pharmaceuticals (EYPT) Q4 Earnings: A Look at Key Metrics [Yahoo! Finance]
Low
Report
Compared to Estimates, EyePoint Pharmaceuticals (EYPT) Q4 Earnings: A Look at Key Metrics [Yahoo! Finance]
3/7
07:16 am
eypt
EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Developments [Yahoo! Finance]
Medium
Report
EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Developments [Yahoo! Finance]
3/7
07:00 am
eypt
EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Developments
Medium
Report
EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Developments
3/4
07:17 am
eypt
EyePoint Pharmaceuticals Announces Appointment of Ramiro Ribeiro, M.D., Ph.D. as Chief Medical Officer [Yahoo! Finance]
Medium
Report
EyePoint Pharmaceuticals Announces Appointment of Ramiro Ribeiro, M.D., Ph.D. as Chief Medical Officer [Yahoo! Finance]
3/4
07:00 am
eypt
EyePoint Pharmaceuticals Announces Appointment of Ramiro Ribeiro, M.D., Ph.D. as Chief Medical Officer
Medium
Report
EyePoint Pharmaceuticals Announces Appointment of Ramiro Ribeiro, M.D., Ph.D. as Chief Medical Officer